4.7 Article

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies

Journal

CLINICAL INFECTIOUS DISEASES
Volume 73, Issue -, Pages S177-S179

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciab486

Keywords

respiratory syncytial virus; community mortality; burden

Funding

  1. Bill & Melinda Gates Foundation

Ask authors/readers for more resources

The Bill & Melinda Gates Foundation supported RSV mortality surveillance studies in low- and middle-income countries, revealing high mortality rates among infants and providing important information for the development of RSV immunization products.
The Bill & Melinda Gates Foundation supported respiratory syncytial virus (RSV) mortality surveillance studies in several low- and middle-income countries to address the striking gap in community mortality burden data from these geographies. The compelling findings generated from these studies reveal a high unmeasured burden of community RSV mortality, particularly among infants aged <6 months who are the target population for RSV immunization products currently in late-stage clinical development. These findings should inform revised global RSV mortality estimates and inform policy decisions on RSV vaccine financing and prioritization at the global and national levels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available